Tekla World Healthcare FundTHW -1.35%57 PS Ratio is 6.87 as of Jul. 08, 2026, which is 26% below its 10-year median of 9.30. GuruFocus rates THW with a GF Score™ of 57/100 and a GF Value™ of $19.36 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 1,407 Asset Management companies, Tekla World Healthcare Fund ranks better than 51.39% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Tekla World Healthcare Fund's share price is $13.485.
Tekla World Healthcare Fund's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $1.96. Hence, Tekla World Healthcare Fund's PS Ratio for today is 6.87.
Warning Sign:
Tekla World Healthcare Fund stock PS Ratio (=10.04) is close to 1-year high of 10.13.
The historical rank and industry rank for Tekla World Healthcare Fund's PS Ratio or its related term are showing as below:
THW'
s PS Ratio Range Over the Past 10 Years
Min: 4.15 Med: 9.3 Max: 16.2
Current: 6.86
During the past 9 years, Tekla World Healthcare Fund's highest PS Ratio was 16.20. The lowest was 4.15. And the median was 9.30.
THW's PS Ratio is ranked better than 51.39% of 1407
companies
in the Asset Management industry
Industry Median: 7.21
vs THW: 6.86
During the past 9 years, Tekla World Healthcare Fund's highest 3-Year average Revenue per Share Growth Rate was 31.70% per year. The lowest was -75.90% per year. And the median was -0.10% per year.
Back to Basics: PS Ratio
Tekla World Healthcare Fund (NYSE:THW) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Tekla World Healthcare Fund PS Ratio Related Terms
Tekla World Healthcare Fund PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Asset Management subindustry, Tekla World Healthcare Fund's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Tekla World Healthcare Fund PS Ratio vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Tekla World Healthcare Fund's PS Ratio distribution charts can be found below:
* The bar in red indicates where Tekla World Healthcare Fund's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Tekla World Healthcare Fund's Share Price of today is $13.485.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Tekla World Healthcare Fund's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $1.96.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Tekla World Healthcare Fund (THW) has a PS Ratio of 6.87 as of Jul. 08, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Tekla World Healthcare Fund and its competitors. This is 26% below median its historical median of 9.30. Over the past decade, Tekla World Healthcare Fund's PS Ratio has ranged from 4.15 to 16.20. According to the industry distribution chart, Tekla World Healthcare Fund ranks #684 out of 1407 companies in the Asset Management industry, placing it in the top 48.6%.
Is Tekla World Healthcare Fund's PS Ratio too high?
Tekla World Healthcare Fund's current PS Ratio of 6.87 is 26% below median its 10-year median of 9.30. Over the past 10 years, this metric has ranged from a low of 4.15 to a high of 16.20. The Asset Management industry median PS Ratio is 7.21. Tekla World Healthcare Fund's value of 6.87 is 4.7% below this industry median. Based on the distribution chart, Tekla World Healthcare Fund ranks #684 out of 1407 companies in the Asset Management industry, which is above the industry midpoint. Overall, Tekla World Healthcare Fund has a GF Score™ of 57/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Tekla World Healthcare Fund's PS Ratio compare to MSIF and IQI?
According to the Asset Management industry distribution chart, Tekla World Healthcare Fund ranks #684 out of 1407 companies for PS Ratio. This puts Tekla World Healthcare Fund in the upper half of its industry. The industry median PS Ratio is 7.21. Tekla World Healthcare Fund's value of 6.87 is 4.7% below this benchmark. Historically, Tekla World Healthcare Fund's own PS Ratio has ranged from 4.15 to 16.20 over the past decade. While the company's 10-year median is 9.30 vs. the industry median of 7.21, Tekla World Healthcare Fund has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for an Asset Management company?
The median PS Ratio among Asset Management companies is 7.21, based on 1,407 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Tekla World Healthcare Fund's current PS Ratio of 6.87 is 4.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Tekla World Healthcare Fund and its competitors. For the Asset Management industry, the median PS Ratio is 7.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Tekla World Healthcare Fund's current PS Ratio is 6.87, which is 26% below median its own 10-year median of 9.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Tekla World Healthcare Fund stock overvalued right now?
Based on GuruFocus' analysis, Tekla World Healthcare Fund (THW) is currently considered Significantly Undervalued. The stock's GF Value™ is $19.36, compared to a current price of $13.49 — trading 30.3% below its estimated fair value. The current PS Ratio is 6.87, which is 26% below median its 10-year median of 9.30 and 4.7% below the Asset Management industry median of 7.21. Tekla World Healthcare Fund's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Tekla World Healthcare Fund (THW), the current PS Ratio is 6.87 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Tekla World Healthcare Fund (THW) Overvalued in 2026?
Based on GuruFocus' analysis, Tekla World Healthcare Fund stock appears to be undervalued.
The current stock price of $13.49 is trading 30.3% below its estimated GF Value™ of $19.36.
GuruFocus considers Tekla World Healthcare Fund to be Significantly Undervalued.
Key valuation signals for THW:
PS Ratio: 6.87 (26% below median its 10-year median of 9.30)
GF Value™: $19.36 vs. price of $13.49 (30.3% below fair value)
Industry Position: 4.7% below the Asset Management median (#684 of 1407)
No single metric tells the full story. See the THW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.
57GF Score
Get the complete analysis for THW
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
THW has been successfully added to your 
